These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3786825)

  • 1. Testimony at congressional hearing on biotechnology--July 23, 1986.
    Recomb DNA Tech Bull; 1986 Sep; 9(3):133-210. PubMed ID: 3786825
    [No Abstract]   [Full Text] [Related]  

  • 2. Testimony of the American Society for Microbiology before the House Subcommittee on Investigations and Oversight, House Subcommittee on Natural Resources, Agriculture Research and Environment, and the House Subcommittee on Science, Research and Technology of the House Committee on Science and Technology. Hearing on "The coordinated framework for the regulation of biotechnology", July 23, 1986.
    Riley M
    Recomb DNA Tech Bull; 1986 Sep; 9(3):151-61. PubMed ID: 3466239
    [No Abstract]   [Full Text] [Related]  

  • 3. Congressional hearing on the adequacy of current statutes and scientific knowledge for the regulation of biotechnology.
    Milewski E
    Recomb DNA Tech Bull; 1985 Mar; 8(1):7-16. PubMed ID: 3858924
    [No Abstract]   [Full Text] [Related]  

  • 4. Opening statement: Joint hearing on federal coordination policy for biotechnology, July 23, 1986.
    Walgren D
    Recomb DNA Tech Bull; 1986 Sep; 9(3):137-8. PubMed ID: 3786827
    [No Abstract]   [Full Text] [Related]  

  • 5. Testimony of Assistant Administrator for Pesticides and Toxic Substances, U.S. Environmental Protection Agency before the Subcommittee on Investigations and Oversight, the Subcommittee on Natural Resources, Agriculture Research and Environment, and the Subcommittee on Science, Research and Technology of the U.S. House of Representatives Committee on Science and Technology, July 23, 1986.
    Moore JA
    Recomb DNA Tech Bull; 1986 Sep; 9(3):178-85. PubMed ID: 3786829
    [No Abstract]   [Full Text] [Related]  

  • 6. Washington Insider: Congressional impasse on human cloning.
    Doerflinger RM
    Natl Cathol Bioeth Q; 2004; 4(1):19-25. PubMed ID: 15192847
    [No Abstract]   [Full Text] [Related]  

  • 7. Committee on Science and Technology, U.S. House of Representatives, Washington, D.C. 20515. Opening statement: Subcommittee on Investigations and Oversight, July 23, 1986.
    Volkmer HL
    Recomb DNA Tech Bull; 1986 Sep; 9(3):134-6. PubMed ID: 3786826
    [No Abstract]   [Full Text] [Related]  

  • 8. Statement of Assistent Director, Biological, Behavioral and Social Sciences, National Science Foundation before the Subcommittee on Science, Research, and Technology, U.S. House of Representatives, July 23, 1986.
    Kingsbury DT
    Recomb DNA Tech Bull; 1986 Sep; 9(3):139-50. PubMed ID: 3786828
    [No Abstract]   [Full Text] [Related]  

  • 9. United States Department of Agriculture statement of Assistant Secretary for Science and Education before the House Committee on Science and Technology, July 23, 1986, Subcommittee on Investigations and Oversight and Subcommittee on Science, Research and Technology and Subcommittee on Natural Resources, Agricultural Research and Environment.
    Bentley OG
    Recomb DNA Tech Bull; 1986 Sep; 9(3):186-94. PubMed ID: 3786830
    [No Abstract]   [Full Text] [Related]  

  • 10. Congressional hearing on the environmental implications of genetic engineering.
    Milewski E
    Recomb DNA Tech Bull; 1983 Sep; 6(3):103-10. PubMed ID: 6579582
    [No Abstract]   [Full Text] [Related]  

  • 11. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 12. Testimony of the Industrial Biotechnology Association before the Subcommittees on Natural Resources, Agriculture Research and Environment; Science, Research and Technology; and Investigations and Oversight of the Committee on Science and Technology, House of Representatives, July 23, 1986.
    Godown R
    Recomb DNA Tech Bull; 1986 Sep; 9(3):203-10. PubMed ID: 3786832
    [No Abstract]   [Full Text] [Related]  

  • 13. Profile: Einer Elhauge.
    Ratner M
    Nat Biotechnol; 2006 Feb; 24(2):125. PubMed ID: 16465144
    [No Abstract]   [Full Text] [Related]  

  • 14. Testimony of the American Society for Medical Technology before the Center for Disease Control's Public Hearing on proposed personnel standards.
    Price GD
    Am J Med Technol; 1980 Aug; 46(8):597-602. PubMed ID: 6252778
    [No Abstract]   [Full Text] [Related]  

  • 15. The congressional process. An overview of how a bill becomes a law.
    Schmidt TL
    J Am Coll Health Assoc; 1980 Apr; 28(5):291-4. PubMed ID: 7365161
    [No Abstract]   [Full Text] [Related]  

  • 16. AHCA's Congressional Conference: congressional review of administrative rulemaking (H.R. 1776).
    J Am Health Care Assoc; 1979 Jul; 5(4):15-6. PubMed ID: 10243197
    [No Abstract]   [Full Text] [Related]  

  • 17. Human-nonhuman chimeras: a regulatory proposal on the blurring of species lines.
    Kopinksi NE
    Boston Coll Law Rev; 2004 May; 45(3):619-66. PubMed ID: 16514749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The congressional process.
    Schmidt TL
    Group Pract; 1980 Jan; 29(1):9-11, 28-9. PubMed ID: 10309081
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration hints at clampdown on biotechnology exports.
    Budiansky S; David P
    Nature; 1984 May 31-Jun 6; 309(5967):389. PubMed ID: 6587188
    [No Abstract]   [Full Text] [Related]  

  • 20. Bayh-Dole: if we knew then what we know now.
    Boettiger S; Bennett AB
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.